Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
about
Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home settingBeyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid TumorsThe novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell linesThe histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells.A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity.Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinomaFunctions of the poly(ADP-ribose) polymerase superfamily in plants.Therapeutic potential of PARP inhibitors for metastatic breast cancer.The role of PARP1 in the DNA damage response and its application in tumor therapy.Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma.Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy.Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future Directions.Targeting deficient DNA damage repair in gastric cancer.Inhibition of poly(ADP-ribose) polymerase (PARP) induces apoptosis in lung cancer cell lines.Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis.
P2860
Q23923997-5BE84599-FCCB-4813-A6A1-119686FAADDFQ26852274-855C264F-CB82-4148-AA17-CA34532C532DQ34781882-1588D460-89F1-438D-9C1C-67F209A4BB01Q35146271-5277540F-8997-4EC5-9D65-A083EFE2247AQ35681896-83395B50-5E66-4D74-8A99-0E5770E1F484Q36884862-7B7F857B-A2D3-49BE-A5F4-64D54EEBFD29Q37921198-C86AAD27-8CF2-4F0E-A287-A673A756E09BQ37931893-6CCA0B8A-73B4-42FE-9F53-8CCD0A643EFEQ38015737-9B7B80F4-F40B-42D1-8F77-A643A486B105Q38066230-6A9157C2-CF7C-44FE-B690-623D697C5D07Q38644956-B9561CB6-E402-45A7-95F9-959E397BD81BQ38653626-C7B3A470-1A7F-4CDE-AFCF-3E87C1FC2335Q38834760-E43BE0BB-B265-4219-8DCA-A39F8AE2485DQ39455969-8DE9205D-42B0-4493-B84A-F441A5D62515Q49262129-E4ACC3FE-E742-4F03-AB62-B1FD79A0EC89
P2860
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
@en
type
label
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
@en
prefLabel
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
@en
P2093
P2860
P356
P1476
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
@en
P2093
Andreas du Bois
Florian Heitz
Michael Papsdorf
Nina Ewald-Riegler
Philipp Harter
Stefan Kommoss
P2860
P304
P356
10.1586/ERA.10.53
P577
2010-07-01T00:00:00Z